key: cord-0995916-5r1weauq authors: Franceschi, V. B.; Ferrareze, P. A. G.; Zimerman, R. A.; Cybis, G. B.; Thompson, C. E. title: Mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in Brazil, February 2020 to February 2021: insights and limitations from uneven sequencing efforts date: 2021-03-12 journal: nan DOI: 10.1101/2021.03.08.21253152 sha: ca48a5e988d671c42c006b3c353667fdcabf57cd doc_id: 995916 cord_uid: 5r1weauq The COVID-19 pandemic has already reached approximately 110 million people and it is associated with 2.5 million deaths worldwide. Brazil is the third worst-hit country, with approximately 10.2 million cases and 250 thousand deaths. Unprecedented international efforts have been established in order to share information about epidemiology, viral evolution and transmission dynamics. However, sequencing facilities and research investments are very heterogeneous across different regions and countries across the globe. The understanding of the SARS-CoV-2 biology is a vital part for the development of effective strategies for public health care and disease management. This work aims to analyze the available genomes sequenced in Brazil between February 2020 and February 2021, in order to identify mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in the Brazilian territory by using phylogenetics and phylodynamics analyses from high-quality genomes. We describe heterogeneous and episodic sequencing efforts, the progression of the different lineages along time, evaluating mutational spectra and frequency oscillations derived from the prevalence of novel and specific lineages across different Brazilian regions. We found at least seven major (1-7) and two minor clades (4.2 and 5.3) related to the six most prevalent Brazilian lineages and described its distribution across the Brazilian territory. The emergence and recent frequency shift of lineages (P.1 and P.2) containing mutations of concern in the spike protein (e. g., E484K, N501Y) draws attention due to their association with immune evasion and enhanced receptor binding affinity. Improvements in genomic surveillance are of paramount importance and should be extended in Brazil to better inform policy makers and enable precise evidence-based decisions to fight the COVID-19 pandemic. After its initial emergence in China in late 2019 , Severe Acute Respiratory Syndrome 2 Virus (SARS-CoV-2) has spread rapidly around the world causing the COVID-19 pandemic (World Health Organization 2020) . New epicenters of the disease have been established throughout 2020, mainly in Europe, USA, and South America (Ruiu 2020; Pei et al. 2020 ) . As of February 22, 2021, more than 110 million cases and approximately 2.5 million deaths worldwide have been confirmed (Johns Hopkins Coronavirus Resource Center, 2021) . Several countries are currently experiencing second waves of infections, decreasing optimism regarding a brief solution to the pandemic. Since the sequencing of the first SARS-CoV-2 genome (Zhou et al. 2020) , international efforts of open science have been established through data sharing in the GISAID database (Shu and McCauley 2017) . These sequencing and metadata information were made public and have enabled the study of the viral spread pattern through space and time (Pybus and Rambaut 2009 ) . However, sequencing facilities and research investments are very heterogeneous across the world. Asian, European, North American and Oceanian countries have contributed with more data proportionally to the number of cases (Furuse 2021) , while African and South American genomic surveillance have been more limited. Disparities are even deeper on an individual country basis. For instance, while the United Kingdom leads sequencing efforts (5.85% of cases sequenced), Brazil has sequenced only 0.03% of all its cases, despite being the third worst-hit country, with approximately 10.2 million cases and 250 thousand deaths. Many studies were performed to characterize early viral introductions and transmission dynamics in several countries ( e. g. China (Lu et al. 2020) , USA (Deng et al. 2020; Worobey et al. international travel restrictions have been demonstrated (Candido et al. 2020b) . Unfortunately, little is known about the viral evolution in the entire Brazilian territory after these earliest studies. More recently, new SARS-CoV-2 lineages have been emerged and are considered as "Variants Of Concern" (VOC) , mainly those carrying mutations in the spike (S) glycoprotein due to its role in binding to the human ACE2 receptor (hACE2), allowing the virus to invade the host cell. Up to February 2021, there are three VOCs described worldwide, namely: B.1.1.7, B.1.351, and P.1. The former emerged in England in mid-September 2020 and it is characterized by 14 lineage-specific amino acid substitutions, especially N501Y (a key contact residue interacting with hACE2) and P681H (one of four amino acids comprising the insertion that creates a novel furin cleavage site between S1 and S2) in the S protein (Rambaut et al. 2020b ) . The second emerged in South Africa in October 2020 and harbor a constellation of mutations in Receptor Binding Domain (RBD) of the S protein (especially K417N, E484K and N501Y) (Tegally et al. 2020) . The last and more recent lineage is P.1, derived from B.1.1.28, a widespread lineage from Brazil. It was recently reported in returning travelers from Manaus (Amazonas, Brazil), after arriving in Japan. It has the same three mutations (except for K417T instead of 417N) in the RBD as the South African lineage, but it arose independently (Faria et al. 2021a ) . Importantly, B.1.351 and P.1 carry the E484K mutation associated with escape from neutralizing antibodies, which may be passively acquired by convalescent plasma or actively induced by vaccination (Baum et al. 2020; Weisblum et al. 2020; Greaney et al. 2020) . Recently, a E484K harboring virus was identified in a reinfected patient (Nonaka et al. 2021) from Brazil, confirming the ability to evade naturally developed antibodies from previous infection as well. Moreover, all three VOC lineages harbor N501Y mutation, already associated with enhanced receptor binding affinity , which could lead to increased infectiousness. It is believed that after more than a year of its emergence, some mutations of SARS-CoV-2 ( e. g. E484K and N501Y) have been positively selected, since they may confer adaptive advantages leading to convergent evolution in different lineages spreading across multiple countries. Despite the low sequencing rate, a deeper analysis of mutations and lineages throughout the Brazilian states would allow a better understanding of the relative importance of different mutations and their contribution to global viral diversity. Thus, we aimed to identify 4 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in the Brazilian territory by using phylogenetics and phylodynamics analyses from high-quality SARS-CoV-2 genome sequences. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. Complete SARS-CoV-2 genomes (>29,000 bp) and the associated metadata were obtained from the GISAID database. Considering 2,751 available sequences from Brazil submitted until February 16 2021, 2732 were retrieved applying filters for human host and complete collection date. Number of cases per state per day and across Brazil were downloaded from https://covid19br.wcota.me/en/ (Cota 2020) on the same date. This initiative aggregates data from the Brazilian Ministry of Health and epidemiological bulletins of each federative unit. The GenBank RefSeq sequence NC_045512.2 from Wuhan (China) All available SARS-CoV-2 genomes (537,360 sequences) were retrieved from GISAID on February 16, 2021. These sequences were then subjected to analysis inside NextStrain ncov pipeline ( https://github.com/nextstrain/ncov ; Hadfield et al. 2018 ) through a Brazilian-focused subsampling scheme using time-and worldwide-representative contextual samples. In this workflow, sequences were filtered out based on high divergence, incompleteness and sampling date availability. Next, filtered genomes were aligned using nextalign v0.1.6 ( https://github.com/neherlab/nextalign ) and their ends were masked (100 positions in the beginning, 50 in the end). Maximum likelihood (ML) phylogenetics tree was built using IQ-TREE 6 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101 /2021 .03.08.21253152 doi: medRxiv preprint v2.0.3 (Nguyen et al. 2015 , employing the best-fit model of nucleotide substitution as selected by ModelFinder (Kalyaanamoorthy et al. 2017) . The root of the tree was placed between lineage A and B (Wuhan/Hu-1/2019 and Wuhan/WH01/2019). The clock-like behavior of the inferred tree was inspected using TempEst v1.5.3 (Rambaut et al. 2016) to generate the root-to-tip regression against sampling dates (correlation coefficient = 0.83, R 2 = 0.68). Sequences that deviate more than four interquartile ranges from the root-to-tip regression were removed from the analysis. Time-scaled ML phylogenetics tree was generated using TreeTime v0.8.1 under a strict clock and a skyline coalescent prior with a rate of 8x10 -4 substitutions per site per year . Results were then exported to JSON format to enable interactive genetic and geographical visualization using Auspice. Additionally, ML and time-stamped trees were visualized using is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. Sequencing efforts from Brazil were concentrated mainly in the first epidemic wave (March to April, 2020) ( Figure 1A ). In March, 503 genomes (8.64% of the confirmed cases) and in April, 942 sequences (1.16% of the cases) were sampled. All following months fell below 1% of sequencing rate (Table S1 ). All Brazilian states sequenced less than 0.1% of the confirmed cases through the first year of the pandemic ( Figure 1B ). From the Southeast region, the states of Rio de Janeiro (0.09%) and São Paulo (0.06%) have led the country's sequencing initiatives, followed by Rio Grande do Sul (0.045%) from the South region, Amazonas (0.041%) from the North region and Pernambuco (0.040%) from the Northeast region. The Centre-West was the region with the lowest sequencing rate ( Figure 1B , Table S2 ). The Southeast region contributed with 1,704 genomes (62.53%), followed by Northeast (n=359; 13.17%), South (n=319; 11.71%), North (n=310; 11.38%), and Centre-West (1.21%) regions ( Figure 1C , Table S3 ). In total, 59 different lineages were detected in Brazil, and the states sequencing more genomes (São Paulo, Rio de Janeiro and Rio Grande do Sul) detected higher numbers of circulating lineages (33, 17 and 16, respectively) ( Figure 1D , Table S3 ). Importantly, all States that sequenced at least 100 genomes identified ≥ 10 lineages (Table S3 ). A total of 3,919 mutations were detected across the 2,731 Brazilian genomes and only 354 (12.96%) occured in >5 sequences, 44 (1.61%) in >50 genomes, and 38 (1.39%) in >100 sequences ( Figure 2 , Table 1 ). Twenty-five (65.79%) of these 38 mutations were non-synonymous. Of these, 11 (44.0%) were in the spike protein, 5 (20.0%) in the nucleocapsid protein, and 5 (20.0%) in the ORF1ab polyprotein (Table 1) . Three mutations were found in >95% of the genomes: A23403G (S:D614G), C14408T is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; found in high abundance. The G25088T (S:V1176F) replacement from B.1.1.28 occured in 47.56% of all sequences, while T29148C (N:I292T) and T27299C (ORF6:I33T) from B.1.1.33 in ≈32.5%. The G23012A (S:E484K) mutation in the Receptor Binding Domain (RBD) of spike that recently emerged independently in three Brazilian lineages (B.1.1.33, P.1 and P.2) is already among the most frequent detected up to February, 2021 (11.42%). The E484K viruses have been spreading mostly between mid-2020 up to early-2021. Additionally, the multiple lineage-defining mutations found in emergent P.1 and P.2 lineages from Brazil were observed in >100 and >200 genomes, respectively ( Figure 2 , Table 1 ). In March 2020, the majority of Brazilian sequences belonged to 3 lineages: B.1 (n=101; 20.08%), B.1.1.28 (n=156; 31.01%) and B.1.1.33 (n=131; 26.04%). The first was probably introduced in Brazil through multiple imports from other continents, and the others probably emerged from community transmission inside the country (Candido et al. 2020b From December 2020 onward, the VOC P.1 emerged in Manaus and has been established, together with P.2, as the most prevalent lineages represented by sequencing data ( Figure 3A ). Southern regions sequenced a larger proportion of B.1.1.28 and B.1.1.33 viruses. The Northeast apparently has a slightly different dynamics, since B.1.1.74 (n=138; 38.44%) is the most prevalent lineage followed by B.1.1.33 (n=91; 25.35%). In the Northern region, P.2 is already the second most prevalent lineage (n=81; 26.13%) ( Figure 3B and 3C), but this may be related to the low quantity of sequences from the beginning of the pandemic, and the higher surveillance in the region at present, due to enhanced sequencing efforts after the emergence of P.1. In the Centre-West, the extremely low sequencing rate prevents us from making any assumptions about the genetic diversity of the circulating lineages ( Figure 3B ). . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint suggesting a more geographically restricted distribution. Additionally, the contribution of other lineages that are not among the 10 most frequent in the country are apparently limited ( Figure 3C and Figure S1 ). The time between the first and last detection of the 18 lineages represented by more than five Brazilian genomes varied markedly, with a mean of 186.28 days, median of 179.0 days and standard deviation of 119.58 days. Eleven of the 18 lineages were sampled in different states between the first and last detection, suggesting its spread through the Brazilian territory (Table S4) . (Faria et al. 2021a ) . P.2 was discovered in mid-April 2020, but has been increasing rapidly in frequency since August 2020 ( Figure 3A , Figure S2 ). We obtained 10,573 time-, geographical-and genetic-representative genomes to proceed phylogenetic inferences. Of these, 1,135 were from Africa, 1,963 were from Asia, 3,248 from Europe, 612 from North America, 285 from Oceania, and 3,330 from South America. Among the latter, 2,350 were from Brazil. The maximum likelihood tree showed the evolutionary diversity of SARS-CoV-2 sequences across Brazilian territory ( Figure 4A ). Almost all sequences from Brazil harbor the S:D614G and ORF1b:P314L, which were imported from other continents to Brazil (mainly to Southeastern states) 10 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint massive community transmission and the establishment of local clusters ( Figure 6D ). Clade 4 (n=107) is characterized by B.1.1.74 sequences and it is more geographically restricted to the Northeast, especially Pernambuco (n=41) and Paraiba (n=23). However, it accounts for occasional introductions to Southern and Southeastern regions ( Figure 6E ). Clade 5 harbors B.1.1.28 (Clade 5.1) and P.1 (Clade 5.2) sequences. B.1.1.28 sequences are mostly widespread in Northern and Southeastern regions ( Figure 6F ), and P.1 genomes (n=96) are mostly found in Northern Brazil, specially Amazonas (n=50) and Rondônia (n=15), and Southeast (São Paulo; n=17) ( Figure 6H ). Clade 6 is also represented by genomes that fall into the B.1.1.28 lineage (n=529). However, it is more widespread in the Southeast (n=436), especially in São Paulo (n=412) and in the Southern region (n=72), especially Rio Grande do Sul (n=65) ( Figure 6G ). Clade 7 is highly supported by sequences of P.2 lineage (n=204), which harbor B.1.1.28 defining mutations and its proper ones. This clade is also widely distributed throughout Brazilian regions, especially the Southeast (n=83), South (n=63), and North (n=42), even giving rise to new local clusters in the end of 2020 and early-2021 ( Figure 6H ). . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint Viral sequencing is essential to track viral evolution and spread patterns. Despite the initial efforts to obtain a representative genomic dataset of the Brazilian first epidemic wave to better characterize viral introductions and early spread (Candido et al. 2020b) , the initiatives across different regions have been limited and non-uniform after on. Interestingly, the previously described clades (Candido et al. 2020b) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; distribution of cases and deaths was more spatially uniform, while in other Southeastern states it was more centralized around capital cities (Xavier et al. 2020) . Studies from Rio de Janeiro (Southeast) and Rio Grande do Sul (South) identified B.1.1.28 and B.1.1.33 in higher proportion from April to December 2020 (Voloch et al. 2020; Franceschi et al. 2021; Francisco Jr et al. 2021) . The emergence of a B.1.1.28-derived lineage carrying the E484K mutation (after named P.2) was dated in July 2020, however it began to appear more frequently and almost simultaneously in October 2020 in the Rio de Janeiro state (Voloch et al. 2020 ) and in the small municipality of Esteio, Rio Grande do Sul (Franceschi et al. 2021 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint immediate ancestor (B.1.1.28), molecular selection analyses found evidence that 9 of these 10 mutations are under diversifying positive selection (Faria et al. 2021b ) . Detecting mutations that are subjected to positive pressure is of paramount importance in order to predict the SARS-CoV-2 pandemic future. By correlating amino acid replacements with expected structural changes, it is possible to anticipate risk of immune evasion with consequent infection recurrence and or vaccine mismatching. Various specific mutations were encountered in different lineages that are potentially associated with selective advantages. RBD and its hACE-2 interacting core, the Receptor Binding Motif (RBM), is of evident importance, since substitutions in this motif were associated with increased receptor binding forces ( e. g. , N501Y) or immune evasion ( e.g. , E484K). The E484K seems to be of particular relevance, as its presence shifts the main interaction residue to this site. Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces a higher number of conformational changes than N501Y mutant alone, potentially resulting in an escape mutant (Nelson et al. 2021) . Since this site is not involved in interaction with hACE-2 when the original glutamate is in place, its occurrence has been linked to reinfection, convalescent plasma activity abolishment and decreased post-vaccination neutralizing activity (Nelson et al. 2021; Li et al. 2021 ) . Other mutations likely play important roles by allosteric mechanisms and have been positively selected early during the SARS-CoV-2 pandemic. Almost all Brazilian sequences harbor S:D614G, a hallmark of the ancestral B.1 lineage. Although this mutation is outside the RBD, it is speculated that it abolishes the hydrogen bond between the 614 position in S1 and a threonine residue located at S2 from the neighbour protomer. In consequence, RBD would be locked in its activated "up" position, thus increasing viral infectivity (Ozono et al. 2021) . Therefore, the establishment of this mutation in Brazilian sequences seems to be related to either a founder effect is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; to major evolutionary leaps. Critically ill and immunosuppressed patients chronically infected with SARS-CoV-2 and treated with convalescent plasma have been linked to viral breakthroughs caused by mutant viruses (Kemp et al. 2021) . Whichever phenomena allow for rapid viral evolution, they probably have to permit multiple substitutions to occur almost simultaneously, since our phylodynamics analysis shows constant and relatively slow rates of mutation accumulation, except for VOC viruses. Although the proximal origins of the most important VOCs remain to be determined, some conclusions about their nature could be already drawn. First, the mutations shared between P.1 and B.1.1.351 seem to be associated with a rapid increase in cases even in locations where previous attack rates were thought to be very high (Buss et al. 2020 (Ferrareze et al. 2021; Faria et al. 2021b ) . Our study shows that the Brazilian territory was affected by at least 59 different lineages during the COVID-19 pandemic. This is not completely unexpected, considering the size of the country and its touristic and economical relevance. South African, the original source of B.1.351 lineage, similarly had multiple and diverse viral introductions. Of note, a recent genomic study detected 42 different circulating lineages in the country, between the first epidemic wave (March) and mid-September, 2020. Moreover, the three main lineages (B. 1.1.54, B.1.1.56 and C.1) , which represented the majority of cases in the first wave, were responsible for~42% total of the infections by the end of 2020, since B.1.351 had emerged in an explosive fashion in mid-October (Tegally et al. 2021) . This later lineage is of major concern and South Africa is, up to February 2021, the leader country in COVID-19 related deaths in Africa (Li et al. 2021; Johns Hopkins Coronavirus Resource Center, 2021) . In Brazil, the prevalence of lineages B.1.1.28 and its derivatives P.1 and P.2 have been representing progressively more cases of the sequenced 16 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; genomes by the time of writing. In March, 2020, B.1.1.28 was one of the 28 circulating lineages present in the country, with more than 30% of the sequenced genomes. At its side, B.1.1.33 was the identified lineage for approximately 26% of analyzed genomes. Ten months later (January, 2021), the VOC P.1 appeared as the prevalent one among 12 different lineages, reaching more than 45% of the sequenced cases. Next, followed the P.2 lineage (~27%) . At that point, B.1.1.28 and B.1.1.33, which achieved 85.5% of the sequenced genomes together in June, matched for, in January, less than 10% of the cases. Therefore, in both countries, despite potentially different initial founding effects that could have led to diverse lineage dissemination patterns, eventually complex VOCs harboring advantageous mutations were selected for viral spread, indicating an increased evolutionary fitness for these viruses. Unfortunately, incomplete and erratic sequencing efforts have limited a better SARS-CoV-2 characterization in Brazil, since genomes are not equally distributed in geographical or temporal scales due to episodic sampling efforts prompted by resource availability. This is reflected by a very small fraction of SARS-CoV-2 cases being sequenced. Unequal temporal distribution implies that some of the conclusions are disproportionately affected by events in heavily sampled periods (March-May). Therefore, different lineage distributions could be an artefact of distinct sequencing coverage among states and across different time-frames. Additionally, the majority of the sequences come from the Southeastern region of Brazil. While this is in fact an economic and travel hub for the country, accounting for >70% of the international passengers arriving in Brazil in the beginning of the pandemic (Candido et al. 2020a) , inferences regarding this region can be inflated in relation to undersampled regions. However, this is, to the best of our knowledge, the first attempt to characterize SARS-CoV-2 mutations, phylogenetics, phylogeography and phylodynamics in the entire Brazil after the study that characterized the first epidemic wave in Brazil using 490 representative genomes (Candido et al. 2020b ) . In summary, by systematic analysis of viral genomes distributed across Brazil over time, we were able to confirm the early introductions of multiple lineages, its rapid diversification to constitute new lineages, probable convergent evolution of important mutations ( e. g., is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint newer variants could jeopardize the efficacy of vaccines and immunotherapies and may lead the health care system to overload. We concluded that enhanced genomic surveillance is, therefore, of paramount importance and should be extended as soon as possible as a means to better inform policy makers and enable precise evidence-based decisions to fight the COVID-19 pandemic. A full table acknowledging the authors and corresponding labs submitting sequencing data used in this study can be found in Supplementary File 1. Additional information used and/or analysed during the current study are available from the corresponding author on reasonable request. The authors declare no competing interests. Scholarships and Fellowships were supplied by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior -Brasil (CAPES) -Finance Code 001 and Universidade Federal de Ciências da Saúde de Porto Alegre. The funders had no role in the study design, data generation and analysis, decision to publish or the preparation of the manuscript. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; Tables Table 1. Mutations of Brazilian genomes found in > 100 genomes, associated effects on encoded proteins and major associated lineages. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint (C) Maximum likelihood phylogenetics tree considering only the dynamics inside Brazil. In (B) and (C), state colorings follow the same scheme as (A), except for Northeast, where purple and pink colors define sequences from this region. Tree topology remains the same for these two trees, but node ordering is slightly different. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.08.21253152 doi: medRxiv preprint SARS-CoV-2 Phylogenetic Analysis Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic Routes for COVID-19 importation in Brazil Evolution and epidemic spread of SARS-CoV-2 in Brazil A program for annotating and predicting the effects of single nucleotide polymorphisms Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil Monitoring the number of COVID-19 cases and deaths in Brazil at municipal and federative units level Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus 2021) E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil Genomic sequencing effort for SARS-CoV-2 by country during the pandemic Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition Nextstrain: real-time tracking of pathogen evolution Clinical features of patients infected with 2019 novel coronavirus in Wuhan Johns Hopkins Coronavirus Resource Center COVID-19 Map ModelFinder: fast model selection for accurate phylogenetic estimates SARS-CoV-2 evolution during treatment of chronic infection No higher infectivity but immune escape of SARS-CoV-2 501Y.V2 variants Genomic Epidemiology of SARS-CoV-2 in Guangdong Province Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City Region Recurrent dissemination of SARS-CoV-2 through the Uruguayan-Brazilian border COVID-19 epidemic in the Brazilian state of Amazonas was driven by long-term persistence of endemic SARS-CoV-2 lineages and the recent emergence of the new Variant of Concern P Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies Genomic Evidence of a Sars-Cov-2 Reinfection Case With E484K Spike Mutation in Brazil SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil Differential effects of intervention timing on COVID-19 spread in the United States Evolutionary analysis of the dynamics of viral infectious disease A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil Mismanagement of Covid-19: lessons learned from Italy TreeTime: Maximum-likelihood phylodynamic analysis Tracking the COVID-19 pandemic in Australia using genomics GISAID: Global initiative on sharing all influenza data -from vision to reality Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa Sixteen novel lineages of SARS-CoV-2 in South Africa Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants World Health Organization WHO Director-General's opening remarks at the media briefing on COVID-19 -11 The emergence of SARS-CoV-2 in Europe and North America The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data A pneumonia outbreak associated with a new coronavirus of probable bat origin We thank the administrators of the GISAID database and research groups across the world (especially Brazilians) for supporting the rapid and transparent sharing of genomic data during the COVID-19 pandemic. We also thank the Mayor's Office, Health Department and São Camilo